Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2015 Financial Results
February 26, 2016 10:05 ET
|
Trinity Biotech plc
DUBLIN , Feb. 26, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
Trinity Biotech Announces FDA Submission of High Sensitivity Troponin I Product
December 17, 2015 07:59 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Dec. 17, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB) is pleased to announce today that it has submitted to the U.S. Food and Drug Administration (FDA), for 510(k)...
Trinity Biotech Announces Quarter 3 Financial Results
October 22, 2015 08:36 ET
|
Trinity Biotech plc
DUBLIN, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2015 Financial Results
October 13, 2015 05:45 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Oct. 13, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces Quarter 2 Financial Results Enrolment for the Meritas Troponin ACS Study Now Completed
July 28, 2015 09:29 ET
|
Trinity Biotech plc
DUBLIN, July 28, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2015 Financial Results
July 17, 2015 10:51 ET
|
Trinity Biotech plc
DUBLIN, July 17, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
Trinity Biotech Announces Quarter 1 Results -- EPS 17.4 Cents Dividend of 22 Cents
April 30, 2015 08:23 ET
|
Trinity Biotech plc
DUBLIN, Ireland, April 30, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce First Quarter Fiscal Year 2015 Financial Results
April 23, 2015 05:13 ET
|
Trinity Biotech plc
DUBLIN, Ireland, April 23, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc Closes Offering of $115 Million of 4.00% Exchangeable Senior Notes Due 2045, Including Exercise in Full of Option to Purchase Additional Notes
April 09, 2015 13:05 ET
|
Trinity Biotech plc
DUBLIN, Ireland, April 9, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech Announces Filing of 2014 Annual Report
March 25, 2015 12:21 ET
|
Trinity Biotech plc
DUBLIN, March 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...